About this data
Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.
Glimepiride
- Company
- Washington University School of Medicine
- Mechanism
- Mechanism not yet reported
- Route
- Route not yet reported
- Recruiting trials
- 1 recruiting
Efficacy results: Not yet reported
1 recruiting study currently listed on ClinicalTrials.gov.
Data source: ClinicalTrials.gov · trial data as of Oct 17, 2026
Find a Clinical Trial Near Me
See recruiting studies for Glimepiride and check eligibility with the study team.
Trial details
-
Recruiting NCT NCT07589387
Hypertension Treatment in Nigeria: Hypertension Diabetes Integration Study- Formative Aim 3
Not yet reported Washington University School of Medicine 2800 participants Est. completion 2030-01-31 10 sites Stand-aloneOther conditions: Diabete MellitusView official trial listing → -
Completed NCT NCT00000620
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 10251 participants Est. completion 2012-12 7 sitesCardiovascular diseaseType 2 diabetes Other conditions: Atherosclerosis, Hypercholesterolemia, Hypertension, Diabetes Mellitus, Coronary DiseaseView official trial listing → -
Completed NCT NCT00032487
Glycemic Control and Complications in Diabetes Mellitus Type 2 (VADT)
Not yet reported VA Office of Research and Development 1791 participants Est. completion 2008-05-30 21 sites Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT00044447
Evaluate the Role of Adding Amaryl to Non-Insulin Dependent Diabetes Mellitus Patients Unresponsive to Maximum Dose Metformin & Thiazolidinedione
Not yet reported Sanofi 170 participants Est. completion 2002-09 1 siteOther conditions: Diabetes Mellitus, Non-Insulin-DependentView official trial listing → -
Completed NCT NCT00095030
Study Comparing Muraglitazar With Glimepiride in Type 2 Diabetics Who Are Not Controlled With Metformin Alone
Not yet reported Bristol-Myers Squibb 1752 participants Est. completion 2006-03 206 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT00099944
Efficacy and Safety of Vildagliptin in Combination With Glimepiride in Patients With Type 2 Diabetes
Not yet reported Novartis Pharmaceuticals 515 participants Est. completion 2005-10 1 site Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT00106340
Vildagliptin Compared to Glimepiride in Combination With Metformin in Patients With Type 2 Diabetes
Not yet reported Novartis Pharmaceuticals 3118 participants Est. completion 2008-05-20 2 sites Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT00106704
Sulfonylurea Add-on Study in Patients With Type 2 Diabetes Mellitus (0431-035)
Not yet reported Merck Sharp & Dohme LLC 441 participants Est. completion 2007-01Type 2 diabetesView official trial listing → -
Completed NCT NCT00131664
Avandia™ + Amaryl™ or Avandamet™ Compared With Metformin (AVALANCHE™ Study)
Not yet reported Canadian Heart Research Centre 391 participants Est. completion 2008-01 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT00133718
A 2 Year Trial of Patients With Type 2 Diabetes Focusing on Cardiovascular Diagnostics and Metabolic Control
Not yet reported Asker & Baerum Hospital 120 participants Est. completion 2012-05-29 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT00138580
Extension to a Study on the Efficacy and Safety of Vildagliptin in Combination With Glimepiride in Patients With Type 2 Diabetes
Not yet reported Novartis 345 participants Est. completion 2006-04 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT00151697
LANN-study: Lantus, Amaryl, Novorapid, Novomix Study
Not yet reported Rijnstate Hospital 150 participants 1 siteOther conditions: Diabetes Mellitus Type IIView official trial listing → -
Completed NCT NCT00225264
Efficacy Study of Pioglitazone and Glimepiride on the Rate of Progression of Atherosclerotic Disease.
Not yet reported Takeda 458 participants Est. completion 2006-05 1 site Stand-aloneOther conditions: Diabetes MellitusView official trial listing → -
Completed NCT NCT00225277
Efficacy Study of Pioglitazone Compared to Glimepiride on Coronary Atherosclerotic Disease Progression in Subjects With Type 2 Diabetes Mellitus
Not yet reported Takeda 547 participants Est. completion 2007-10 79 sitesOther conditions: Diabetes MellitusView official trial listing → -
Completed NCT NCT00258804
Insulin Glargine During and After the Period of Fasting in Ramadan
Not yet reported Sanofi 450 participants Est. completion 2006-02Type 2 diabetesView official trial listing → -
Terminated NCT NCT00294723
To Evaluate the Effect of Liraglutide Versus Glimepiride (Amaryl®) on Haemoglobin A1c
Not yet reported Novo Nordisk A/S 746 participants Est. completion 2008-11 117 sites Added to GLP-1Type 2 diabetes Other conditions: DiabetesView official trial listing → -
Completed NCT NCT00309608
Efficacy and Safety of BI 1356 BS (Linagliptin) in Combination With Metformin in Patients With type2 Diabetes
Not yet reported Boehringer Ingelheim 333 participants 48 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT00318422
Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes
Not yet reported Novo Nordisk A/S 1041 participants Est. completion 2007-05 127 sitesType 2 diabetes Other conditions: DiabetesView official trial listing → -
Completed NCT NCT00318461
To Compare the Effect of Liraglutide When Given Together With Metformin With the Effect of Metformin Given Alone and With the Effect of Glimepiride and Metformin Given Together
Not yet reported Novo Nordisk A/S 1091 participants Est. completion 2008-11 190 sites Added to GLP-1Type 2 diabetes Other conditions: DiabetesView official trial listing → -
Completed NCT NCT00318656
24-Hour Glycemia: Rosiglitazone Versus Glimepiride In Type 2 Diabetes
Not yet reported GlaxoSmithKline 23 participants Est. completion 2007-10Other conditions: Non-Insulin-Dependent Diabetes MellitusView official trial listing → -
Completed NCT NCT00331851
Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes
Not yet reported Novo Nordisk A/S 584 participants Est. completion 2007-04 116 sitesType 2 diabetes Other conditions: DiabetesView official trial listing → -
Terminated NCT NCT00343980
Safety and Efficacy of Inhaled Pre-prandial Human Insulin in Type 2 Diabetes
Not yet reported Novo Nordisk A/S 363 participants Est. completion 2008-03-10 26 sites Stand-aloneType 2 diabetes Other conditions: DiabetesView official trial listing → -
Completed NCT NCT00353691
Glimepiride vs Metformin as Monotherapy in Pediatric Subjects With Type 2 Diabetes Mellitus
Not yet reported Sanofi 100 participants Est. completion 2004-11 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT00359762
Exenatide Versus Glimepiride in Patients With Type 2 Diabetes
Not yet reported AstraZeneca 1029 participants Est. completion 2011-03 114 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT00360698
Insulin Glulisine in Type 2 Diabetic Patients
Not yet reported Sanofi 106 participants Est. completion 2008-08 3 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT00363519
Controlled Study of MK-0431/ONO-5435 in Patients With Type 2 Diabetes Mellitus
Not yet reported Ono Pharmaceutical Co., Ltd. 195 participants 8 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT00379769
RECORD: Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes
Not yet reported GlaxoSmithKline 4447 participants Est. completion 2008-12 446 sitesType 2 diabetesView official trial listing → -
Terminated NCT NCT00427154
Effect of Inhaled Pre-prandial Human Insulin on Blood Glucose Control in Type 2 Diabetes
Not yet reported Novo Nordisk A/S 227 participants Est. completion 2008-03-11 103 sitesType 2 diabetes Other conditions: DiabetesView official trial listing → -
Completed NCT NCT00437554
Phase III Study for Glimepiride + Metformin Hydrochloride (Amaryl M) Slow Release (SR)
Not yet reported Handok Inc. 188 participants Est. completion 2007-07 1 siteType 2 diabetesView official trial listing → -
Terminated NCT NCT00449605
A Glycemic Control Evaluation of Glimepiride Versus Rimonabant on Top of Metformin in Type 2 Diabetes
Not yet reported Sanofi 508 participants Est. completion 2009-03 15 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT00469092
Comparison of Biphasic Insulin Aspart 30 Versus Insulin Glargine Both in Combination With Metformin and Glimepiride in Subjects With Type 2 Diabetes
Not yet reported Novo Nordisk A/S 480 participants Est. completion 2008-04 69 sites Stand-aloneType 2 diabetes Other conditions: DiabetesView official trial listing → -
Terminated NCT NCT00469586
Efficacy and Safety of Inhaled Insulin Compared to Metformin and Glimepiride in Type 2 Diabetes
Not yet reported Novo Nordisk A/S 174 participants Est. completion 2008-04-24 59 sitesType 2 diabetes Other conditions: DiabetesView official trial listing → -
Completed NCT NCT00474838
Study To Evaluate Beta Cell Function and Glycemic Outcome by Intensive Insulin Therapy
Not yet reported Kyunghee University Medical Center 112 participants Est. completion 2012-12 8 sitesType 2 diabetes Other conditions: Pancreatic Beta Cell Function, GlucotoxicityView official trial listing → -
Completed NCT NCT00506194
Short-Term Intensive Insulin Therapy Induction of Long-term Glycemic Control
Not yet reported Taipei Veterans General Hospital, Taiwan 60 participants Est. completion 2011-12 1 siteType 2 diabetesView official trial listing → -
Withdrawn NCT NCT00549263
Bioequivalence Study of SB797620 in Healthy Japanese Volunteers
Not yet reported GlaxoSmithKlineOther conditions: Healthy SubjectsView official trial listing → -
Completed NCT NCT00562172
Insulin Glargine (Lantus) vs Sulfonylurea (SU) for BETA Cell Function (BETA Study)
Not yet reported Sanofi 75 participants Est. completion 2010-10 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT00562250
Pharmacokinetic Drug Interaction Study With Dapagliflozin and Glimepiride in Healthy Subjects
Not yet reported AstraZeneca 11 participants Est. completion 2008-08 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT00576784
Metabolic Effects of Pioglitazone in Type II Diabetic Patients Previously Treated With Insulin
Not yet reported IKFE Institute for Clinical Research and Development 100 participants Est. completion 2007-04 1 siteType 2 diabetes Other conditions: Insulin ResistanceView official trial listing → -
Completed NCT NCT00608179
Glimepiride Induced Insulin Secretion Will be Inhibited by Hypoglycemia
Not yet reported Vanderbilt University 32 participants Est. completion 2010-12 Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT00612144
Study Comparing Efficacy and Safety of Amaryl M and Metformin Uptitraion to Type 2 DM
Not yet reported Handok Inc. 192 participants Est. completion 2009-05 1 site Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT00614120
Effect of Liraglutide or Glimepiride Added to Metformin on Blood Glucose Control in Subjects With Type 2 Diabetes
Not yet reported Novo Nordisk A/S 929 participants Est. completion 2009-02 50 sites MixedType 2 diabetes Other conditions: DiabetesView official trial listing → -
Completed NCT NCT00619697
Efficacy and Safety of Biphasic Insulin Aspart 30 in Combination With Metformin in Type 2 Diabetes
Not yet reported Novo Nordisk A/S 260 participants Est. completion 2005-03 54 sitesType 2 diabetes Other conditions: DiabetesView official trial listing → -
Completed NCT NCT00620282
The Effect of Liraglutide on Endothelial Function in Subjects With Type 2 Diabetes Mellitus
Not yet reported Novo Nordisk A/S 49 participants Est. completion 2010-05 1 siteType 2 diabetes Other conditions: DiabetesView official trial listing → -
Completed NCT NCT00622284
Efficacy and Safety of BI 1356 in Combination With Metformin in Patients With Type 2 Diabetes
Not yet reported Boehringer Ingelheim 1560 participants 221 sites Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT00633425
Continuous Glucose Monitoring System (CGMS) in Type 2 Diabetic Patients Inadequately Controlled by Metformine Monotherapy; Analyze of Glycemic Profile Before and After Association of Glimepiride
Not yet reported Sanofi 43 participants Est. completion 2003-10 1 siteOther conditions: Diabetes MellitusView official trial listing → -
Completed NCT NCT00642915
Insulin Glargine Benefits in Japanese Pts Outside of Japan (US or Brazil)
Not yet reported Sanofi 100 participants Est. completion 2004-07 1 siteOther conditions: Diabetes MellitusView official trial listing → -
Completed NCT NCT00648362
Fasting Study of Glimepiride Tablets 1 mg to Amaryl® Tablets 1 mg
Not yet reported Mylan Pharmaceuticals Inc 40 participants Est. completion 2004-12 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT00650533
Food Study of Glimepiride Tablets 1 mg to Amaryl® Tablets 1 mg
Not yet reported Mylan Pharmaceuticals Inc 40 participants Est. completion 2004-12 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT00679237
Risk Reduction in Coronary Heart Disease
Not yet reported Sorlandet Hospital HF 1600 participants Est. completion 2019-12 1 siteOther conditions: Coronary Heart DiseaseView official trial listing → -
Completed NCT NCT00680745
Efficacy and Safety of Dapagliflozin in Combination With Glimepiride (a Sulphonylurea) in Type 2 Diabetes Patients
Not yet reported AstraZeneca 597 participants Est. completion 2010-05 66 sites Stand-aloneType 2 diabetesView official trial listing → -
Status unknown NCT NCT00699322
Effect of Dipeptidyl Peptidase-IV Inhibitor and Sulfonylurea on Glucose Variability and Oxidative Stress
Not yet reported The Catholic University of Korea 36 participants Est. completion 2010-06 1 siteType 2 diabetesView official trial listing → -
Status unknown NCT NCT00700856
Thiazolidinediones Or Sulphonylureas and Cardiovascular Accidents.Intervention Trial
Not yet reported Italian Society of Diabetology 3371 participants Est. completion 2018-12 61 sitesType 2 diabetesCardiovascular diseaseView official trial listing → -
Completed NCT NCT00701090
A Study to Test the Safety and Efficacy of Sitagliptin Compared to Glimepiride in Patients With Type 2 Diabetes on a Stable Dose of Metformin (0431-803)(COMPLETED)
Not yet reported Merck Sharp & Dohme LLC 1035 participants Est. completion 2009-10 Stand-aloneType 2 diabetes Other conditions: Diabetes Mellitus, Non-Insulin-DependentView official trial listing → -
Completed NCT NCT00708578
Optimal Oral Hypoglycaemic Agents (OHA) for Combination With Insulin Glargine (Sulfonylurea vs. Metformin)
Not yet reported Sanofi 99 participants Est. completion 2009-12 1 site Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT00722631
Anti-Inflammatory Effects of Pioglitazone
Not yet reported Kurume University 70 participants Est. completion 2012-04 1 sitePrediabetesType 2 diabetes Other conditions: AtherosclerosisView official trial listing → -
Completed NCT NCT00740051
A Randomised, db, Placebo-controlled Study of BI 1356 for 18 Weeks Followed by a 34 Week Double-blind Extension Period (Placebo Patients Switched to Glimepiride) in Type 2 Diabetic Patients for Whom Treatment With Metformin is Inappropriate
Not yet reported Boehringer Ingelheim 227 participants 53 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT00747383
How Improvement in Control of Diabetes Influences the Production of a Hormone Produced in the Gut Which Improves the Release and Action of Insulin.
Not yet reported The Royal Bournemouth Hospital 74 participants Est. completion 2010-09 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT00770653
Efficacy of Pioglitazone/Metformin Combination Therapy in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia.
Not yet reported Takeda 305 participants Est. completion 2009-05 64 sites Stand-aloneOther conditions: Diabetes Mellitus, DyslipidemiasView official trial listing → -
Completed NCT NCT00770952
Efficacy of Pioglitazone and Glimepiride Combination Therapy in Treating Subjects With Type 2 Diabetes Mellitus.
Not yet reported Takeda 91 participants Est. completion 2008-12 17 sites Stand-aloneOther conditions: Diabetes MellitusView official trial listing → -
Completed NCT NCT00775684
Effect of Exenatide, Sitagliptin or Glimepiride on Functional ß -Cell Mass
Not yet reported University of Pennsylvania 47 participants Est. completion 2012-11 3 sitesPrediabetesType 2 diabetesView official trial listing → -
Completed NCT NCT00776490
Bioequivalence Study of Glimepiride 1mg Tablets Under Fasting Conditions
Not yet reported Ranbaxy Laboratories Limited 32 participants Est. completion 2003-09 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT00776620
Bioequivalence Study of Glimepiride 1mg Tablets Under Fed Conditions
Not yet reported Ranbaxy Laboratories Limited 32 participants Est. completion 2003-09 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT00783744
Insulin Glargine Combination Therapies in Type II Diabetics
Not yet reported Sanofi 375 participants 10 sites Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT00792935
A Study to Test MK-0941 in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-0941-017)
Not yet reported Merck Sharp & Dohme LLC 143 participants Est. completion 2010-02Type 2 diabetesView official trial listing → -
Completed NCT NCT00834340
Glimepiride 4 mg Tablets Under Fasting Conditions
Not yet reported Teva Pharmaceuticals USA 32 participants Est. completion 2003-03 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT00835172
Glimepiride 4 mg Tablets Under Non-Fasting Conditions
Not yet reported Teva Pharmaceuticals USA 32 participants Est. completion 2003-03 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT00838903
Efficacy and Safety of Albiglutide in Treatment of Type 2 Diabetes
Not yet reported GlaxoSmithKline 1049 participants Est. completion 2013-04 386 sites Added to GLP-1Type 2 diabetesView official trial listing → -
Completed NCT NCT00839527
A Study to Determine the Safety and Efficacy of Albiglutide in Subjects With Type 2 Diabetes
Not yet reported GlaxoSmithKline 685 participants Est. completion 2013-04 358 sites Added to GLP-1Type 2 diabetesView official trial listing → -
Completed NCT NCT00842556
Pharmacokinetic Drug Interaction Study of Dapagliflozin and Glimepiride or Sitagliptin in Healthy Subjects
Not yet reported AstraZeneca 18 participants Est. completion 2009-05 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT00858013
Study of the Durability of Glycemic Control With Nateglinide
Not yet reported Ajou University School of Medicine 88 participants Est. completion 2014-06-25 7 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT00908921
Efficacy and Safety of Glimepiride as Oral Anti-Diabetic (OAD) Initiation Mono-therapy in Chinese Type 2 Diabetes Mellitus (T2DM)
Not yet reported Sanofi 391 participants Est. completion 2010-09 1 site Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT00913367
Efficacy/Safety Study of Amaryl®M 1/500 mg Twice Daily Versus Amaryl® 4 mg Both in Combination With Lantus® in Type 2 Diabetes Mellitus
Not yet reported Handok Inc. 110 participants Est. completion 2010-11 1 site Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT00924573
Comparative Study of HOE490 O (Glimepiride and Metformin) Compared With Placebo on Top of Glimepiride
Not yet reported Sanofi 189 participants Est. completion 2010-03 1 site Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT00934323
Dose Proportionality Study About Amaryl M Slow Release (SR) 1/500 mg
Not yet reported Handok Inc. 33 participants Est. completion 2009-04 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT00934817
Dose Proportionality Study Comparing Amaryl-M 1/500 mg and Amaryl-M 2/500 mg
Not yet reported Handok Inc. 36 participants Est. completion 2007-08Other conditions: HealthyView official trial listing → -
Terminated NCT NCT00939939
Effect of Sitagliptin on Postprandial Lipoprotein Metabolism
Not yet reported Ludwig-Maximilians - University of Munich 3 participants Est. completion 2011-05 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT00941161
Effect of Oral Combination Therapy in a Single Dosage Form in Patients With Type 2 Diabetes Mellitus
Not yet reported Laboratorios Silanes S.A. de C.V. 28 participants 1 site Stand-aloneType 2 diabetesView official trial listing → -
Terminated NCT NCT00947557
Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Glimepiride With or Without Metformin
Not yet reported Forest Laboratories 677 participants 147 sitesOther conditions: Diabetes Mellitus, Type IIView official trial listing → -
Completed NCT NCT00949442
Lantus Versus NPH: Comparison in Insulin Naive People Not Adequately Controlled With at Least One Oral Anti Diabetics (OAD) Treatment
Not yet reported Sanofi 708 participants Est. completion 2012-07 87 sites Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT00957060
Superiority of Glimepiride Over Sitagliptin in Naive Type 2 Diabetes Patients
Not yet reported Sanofi 400 participants Est. completion 2010-10 2 sites Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT00968812
CANagliflozin Treatment And Trial Analysis-Sulfonylurea (CANTATA-SU) SGLT2 Add-on to Metformin Versus Glimepiride
Not yet reported Janssen Research & Development, LLC 1452 participants Est. completion 2013-01 138 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT00974090
Efficacy and Safety Study of MP-513 in Combination With Sulfonylurea in Patients With Type 2 Diabetes
Not yet reported Tanabe Pharma Corporation 194 participants Est. completion 2011-03 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT00975065
Galvus on Met Phase 4 Study : Study to Evaluate the Efficacy and Safety of Early Combination of Vildagliptin and Metformin in Patients With Type 2 Diabetes Mellitus
Not yet reported Handok Inc. 266 participants Est. completion 2012-04 1 site Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT00978263
Comparison of Glargine and Oral Antidiabetic Drugs (OADs) in Newly Diagnosed Type 2 Diabetes
Not yet reported Chongqing Medical University 47 participants Est. completion 2012-06 1 site Stand-aloneOther conditions: DiabetesView official trial listing → -
Completed NCT NCT00993187
Efficacy and Safety of Sitagliptin/Metformin Fixed-Dose Combination (FDC) Compared to Glimepiride in Participants With Type 2 Diabetes Mellitus (MK-0431A-202)
Not yet reported Merck Sharp & Dohme LLC 292 participants Est. completion 2013-10-29 Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT01006603
Saxagliptin Compared to Glimepiride in Elderly Type 2 Diabetes Patients, With Inadequate Glycemic Control on Metformin
Not yet reported AstraZeneca 957 participants Est. completion 2012-06 131 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT01007097
Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus
Not yet reported Takeda 426 participants Est. completion 2010-09 71 sites Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT01052909
Bioequivalence Study of Dr.Reddy's Laboratories Limited, Glimepiride Tablets 1 mg Under Fasting Condition
Not yet reported Dr. Reddy's Laboratories Limited 44 participants Est. completion 2003-12 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT01053689
Bioequivalence Study of Dr.Reddys Laboratories Limited, Glimepiride 1 mg Tablets in Healthy Subjects Under Fed Condition
Not yet reported Dr. Reddy's Laboratories Limited 44 participants Est. completion 2003-12 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT01068860
To Compare the Effect of a Subcutaneous Canakinumab Administration to Placebo in Patients With Impaired Glucose Tolerance or Patients With Type 2 Diabetes With Differing Baseline Diabetes Therapies
Not yet reported Novartis 246 participants Est. completion 2010-08 52 sitesType 2 diabetesPrediabetesView official trial listing → -
Completed NCT NCT01075282
A Study in Participants With Type 2 Diabetes Mellitus (AWARD-2)
Not yet reported Eli Lilly and Company 810 participants Est. completion 2012-11 78 sites Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT01076075
A Study to Evaluate the Safety and Efficacy of Sitagliptin 100 mg in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control (MK-0431-229)
Not yet reported Merck Sharp & Dohme LLC 427 participants Est. completion 2012-01-19 Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT01087502
Safety and Efficacy of Linagliptin in Type-2-diabetes Mellitus Patients With Moderate to Severe Renal Impairment
Not yet reported Boehringer Ingelheim 241 participants 52 sites Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT01087567
INSPIRE Diabetes Study: Basal Bolus Insulin as Primary Treatment of Type 2 Diabetes
Not yet reported Ohio University 23 participants Est. completion 2014-01 1 siteType 2 diabetesView official trial listing → -
Terminated NCT NCT01089790
Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus Receiving Background Treatment With Glimepiride Alone or in Combination With Metformin or With Pioglitazone Alone
Not yet reported Forest Laboratories 141 participants 149 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT01099137
Effect of Vildagliptin in Type 2 Diabetes Treated With Sulphonylurea and Metformin
Not yet reported Seoul National University Bundang Hospital 344 participants Est. completion 2013-05 1 siteOther conditions: DiabetesView official trial listing → -
Completed NCT NCT01123980
Comparison of the Blood Sugar Lowering Effect of Biphasic Insulin Aspart 30 and Insulin Glargine Both Combined With Metformin and Glimepiride in Chinese and Japanese Subjects With Type 2 Diabetes New to Insulin Treatment
Not yet reported Novo Nordisk A/S 521 participants Est. completion 2011-06 34 sites Stand-aloneType 2 diabetes Other conditions: DiabetesView official trial listing → -
Completed NCT NCT01131182
Study of Sitagliptin Treatment in Patients With Type 2 Diabetes During Ramadan (0431-263)
Not yet reported Merck Sharp & Dohme LLC 1147 participants Est. completion 2010-11-04Type 2 diabetesView official trial listing → -
Completed NCT NCT01133431
The Pharmacokinetic Interaction Between CKD-501 and Sulfonylurea
Not yet reported Chong Kun Dang Pharmaceutical 24 participants Est. completion 2010-08 1 site Stand-aloneOther conditions: Healthy Male VolunteerView official trial listing → -
Completed NCT NCT01144728
Initiation and Titration of Amaryl
Not yet reported Sanofi 172 participants Est. completion 2010-12 1 site Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT01167881
Efficacy and Safety of Empagliflozin (BI 10773) With Metformin in Patients With Type 2 Diabetes
Not yet reported Boehringer Ingelheim 1549 participants Est. completion 2015-08 182 sites Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT01177384
Clinical Trial to Evaluate the Safety and Efficacy of the Addition of Sitagliptin in Participants With Type 2 Diabetes Mellitus Receiving Acarbose Monotherapy (MK-0431-130)
Not yet reported Merck Sharp & Dohme LLC 380 participants Est. completion 2013-03-25 Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT01183104
START-J: SiTAgliptin in eldeRly Trial in Japan
Not yet reported Japan Association for Diabetes Education and Care 305 participants Est. completion 2015-01 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT01189890
Safety and Efficacy of Sitagliptin Compared With Glimepiride in Elderly Participants With Type 2 Diabetes Mellitus (MK-0431-251)
Not yet reported Merck Sharp & Dohme LLC 480 participants Est. completion 2012-10-31 Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT01195259
Malignancy Meta Analysis for BRL49653
GlaxoSmithKline 1 participants Est. completion 2010-01Type 2 diabetesView official trial listing → -
Completed NCT NCT01204580
ADIponectin and Asymmetric Dimethylarginine (ADMA) Level in Type-2 Diabetes Patients After 12 Weeks of Treatment With GlimepiRide And Metformin Fixed Dose Combination
Not yet reported Sanofi 40 participants Est. completion 2012-03 1 site Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT01233622
Safety and Efficacy of Galvus as add-on Therapy to Metformin Plus Glimepiride
Not yet reported Novartis 317 participants Est. completion 2011-11 55 sites Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT01242215
A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Sulfonylurea in Type 2 Diabetic Patients
Not yet reported Astellas Pharma Inc 243 participants Est. completion 2012-04-25 7 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT01243424
CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes
Not yet reported Boehringer Ingelheim 6103 participants Est. completion 2018-08-21 613 sites Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT01262586
Vildagliptin Glycemic Profiles Assessment Using a Continuous Glucose Monitoring Device.
Not yet reported Novartis Pharmaceuticals 24 participants Est. completion 2011-03 1 siteOther conditions: Type II Diabetes MellitusView official trial listing → -
Completed NCT NCT01278160
Comparison of Biphasic Insulin Aspart 30 Twice Daily With Two Different Initial Dosage Split Regimens in Subjects With Type 2 Diabetes: An Extension to Trial BIASP-3756
Not yet reported Novo Nordisk A/S 179 participants Est. completion 2011-09 1 site Stand-aloneType 2 diabetes Other conditions: DiabetesView official trial listing → -
Completed NCT NCT01296412
Comparison of Two Treatment Regimens (Sitagliptin Versus Liraglutide) on Participants Who Failed to Achieve Good Glucose Control on Metformin Alone (MK-0431-403)
Not yet reported Merck Sharp & Dohme LLC 653 participants Est. completion 2012-02-29 Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT01302158
Drug-drug Interaction Study With ASP1941 and Glimepiride
Not yet reported Astellas Pharma Inc 52 participants Est. completion 2010-04 1 siteOther conditions: Healthy SubjectsView official trial listing → -
Completed NCT NCT01318083
Efficacy and Safety of Alogliptin Used in Combination With Sulfonylurea in Participants With Type 2 Diabetes in Japan
Not yet reported, Not yet reported Takeda 312 participants Est. completion 2009-04Type 2 diabetesView official trial listing → -
Completed NCT NCT01318135
Long-term Safety Study of Alogliptin Used in Combination With Sulfonylurea or Metformin in Participants With Type 2 Diabetes in Japan
Not yet reported, Not yet reported Takeda 576 participants Est. completion 2010-04Type 2 diabetesView official trial listing → -
Completed NCT NCT01340768
Study to Compare Sitagliptin Versus Sulfonylurea Treatment During Ramadan Fasting in Patients With Type 2 Diabetes (MK-0431-262)
Not yet reported Merck Sharp & Dohme LLC 870 participants Est. completion 2011-09-21Type 2 diabetesView official trial listing → -
Completed NCT NCT01341717
Effects of Sitagliptin on Type 2 Diabetes Mellitus Patients on Treatment With Metformin and Insulin
Not yet reported Jothydev's Diabetes and Research Centre 440 participants Est. completion 2014-05 1 site Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT01357135
An Observational Study of Type II Diabetics Treated With Dual Therapy With or Without Sitagliptin (Januvia®/Xelevia®, MK-0431-201)
Merck Sharp & Dohme LLC 3453 participants Est. completion 2013-08-31Type 2 diabetesView official trial listing → -
Completed NCT NCT01357252
Vildagliptin add-on to Glimepiride Versus Placebo Added to Glimepiride in Type 2 Diabetes
Not yet reported Novartis Pharmaceuticals 279 participants Est. completion 2013-01 18 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT01404676
The Effect of Vildagliptin Based Treatment Versus Sulfonylurea on Glycemic Variability, Oxidative Stress, GLP-1, and Endothelial Function in Patients With Type 2 Diabetes
Not yet reported Samsung Medical Center 34 participants Est. completion 2012-05 1 siteType 2 diabetesView official trial listing → -
Withdrawn NCT NCT01408095
A Study in Patients With Type 2 Diabetes
Not yet reported Eli Lilly and Company 240 participants Est. completion 2012-09 38 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT01425580
Liraglutide and Heart Failure in Type 2 Diabetes
Not yet reported Thomas Nystrom 62 participants Est. completion 2016-08 2 sites Added to GLP-1Heart failureType 2 diabetesView official trial listing → -
Completed NCT NCT01429818
Endothelial Disfunction Treatment With Glimepiride/Metformin Combination (Glimetal) in Type 2 Diabetes Patients
Not yet reported Laboratorios Silanes S.A. de C.V. 16 participants Est. completion 2008-01 1 site Stand-aloneOther conditions: Endothelial Dysfunction, Diabetes MellitusView official trial listing → -
Completed NCT NCT01437800
BIOAVAILABILITY OF GLI/METXR (4/850 mg)
Not yet reported Laboratorios Silanes S.A. de C.V. 24 participants Est. completion 2011-03 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT01437813
BIOAVAILABILITY OF Glimepiride/Extended Release Metformin (GLI/METXR): High Fat Diet Study
Not yet reported Laboratorios Silanes S.A. de C.V. 24 participants Est. completion 2011-03 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT01444248
Compare the Compliance of Patients Treated With Once-daily (od) or Twice-daily (Bid) Glimepiride and Metformin Fixed Combination Therapy
Not yet reported Handok Inc. 168 participants Est. completion 2012-05 1 site Stand-aloneType 2 diabetesView official trial listing → -
Terminated NCT NCT01453049
An Efficacy and Safety Study of Fixed-dose Rosiglitazone/Glimepiride to Treat Chinese Type 2 Diabetes Patients
Not yet reported GlaxoSmithKline 86 participants Est. completion 2010-10 12 sites Stand-aloneType 2 diabetesView official trial listing → -
Withdrawn NCT NCT01455883
A Study to Evaluate ITCA 650 Compared to Glimepiride for the Treatment of Type 2 Diabetes
Not yet reported Intarcia Therapeutics Est. completion 2014-07 1 siteType 2 diabetesView official trial listing → -
Withdrawn NCT NCT01455922
A Study to Evaluate ITCA 650 Compared to Glimepiride as Add on Therapy for the Treatment of Type 2 Diabetes
Not yet reported Intarcia Therapeutics Est. completion 2014-07 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT01457911
Evaluation of Fixed Dose Combination of Glimepiride and Metformin in Chinese Type 2 Diabetes Patients Inadequately Controlled With Metformin
Not yet reported Sanofi 244 participants Est. completion 2013-02 22 sites Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT01459809
Efficacy and Safety Comparison of Metformin/Glimepiride Combination Versus Each Compound Alone in New Diagnosed Type 2 Diabetes Patients
Not yet reported Sanofi 538 participants Est. completion 2014-01 55 sites Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT01472497
Effects of Pioglitazone in Hypertensive Patients
Not yet reported Tottori University Hospital 16 participants Est. completion 2012-03 1 siteOther conditions: Hypertension, Insulin ResistanceView official trial listing → -
Terminated NCT NCT01477853
A Study of the Co-administration of Sitagliptin and Atorvastatin in Inadequately Controlled Type 2 Diabetes Mellitus (MK-0431E-211)
Not yet reported Merck Sharp & Dohme LLC 166 participants Est. completion 2012-12-04 Stand-aloneType 2 diabetesView official trial listing → -
Terminated NCT NCT01481116
Efficacy and Safety of TAK-875 Compared to Glimepiride When Used With Metformin in Participants With Type 2 Diabetes
Not yet reported Takeda 2454 participants Est. completion 2014-04 226 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT01494987
Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus
Not yet reported Gilead Sciences 431 participants Est. completion 2013-08 140 sites Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT01495013
A Comparison of Atorvastatin and Glimepiride Fixed Dose Combination and Atorvastatin and Glimepiride Loose Combination in the Treatment of Patients With Type 2 Diabetes Mellitus
Not yet reported GlaxoSmithKline 427 participants Est. completion 2013-09 33 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT01496443
TAK-875 Glimepiride Drug-Interaction Study
Not yet reported Takeda 28 participants Est. completion 2012-05 1 site Stand-aloneOther conditions: PharmacokineticsView official trial listing → -
Completed NCT NCT01509001
Study of Metabolic and Haemodynamic Effects of Metformin and Glimepiride in Patients With Type 2 Diabetes Mellitus
Not yet reported University of Sao Paulo 20 participants Est. completion 2012-01 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT01509755
Comparison of Liraglutide and Glimepiride on Blood Sugar Control in Subjects With Type 2 Diabetes
Not yet reported Novo Nordisk A/S 196 participants Est. completion 2001-10 29 sitesType 2 diabetes Other conditions: DiabetesView official trial listing → -
Completed NCT NCT01511172
Effect of Liraglutide as add-on to Metformin Compared to Either Liraglutide or Metformin Alone, or to a Combination of Metformin and a SU (Sulphonylurea) Agent in Subjects With Type 2 Diabetes
Not yet reported Novo Nordisk A/S 145 participants Est. completion 2002-12 41 sitesType 2 diabetes Other conditions: DiabetesView official trial listing → -
Completed NCT NCT01511692
Effect of Liraglutide Compared to Glimepiride on Appetite in Subjects With Type 2 Diabetes
Not yet reported Novo Nordisk A/S 43 participants Est. completion 2007-09 2 sitesType 2 diabetes Other conditions: DiabetesView official trial listing → -
Completed NCT NCT01517373
Study To Understand Efficacy And Safety Of Investigational Agent (PF-04937319) Compared To Approved Agent (Glimepiride) In Patients With Diabetes On Metformin
Not yet reported Pfizer 304 participants Est. completion 2013-01 53 sitesType 2 diabetesView official trial listing → -
Status unknown NCT NCT01547104
Effect of Linagliptin in Comparison With Glimepiride as Add on to Metformin on Postprandial Beta Cell Function, Postprandial Metabolism and Oxidative Stress in Patients With Type 2 Diabetes Mellitus
Not yet reported Marcus Borchert 40 participants Est. completion 2012-10 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT01561976
Evaluation of Food Effect on the Pharmacokinetics of Sustained Release Metformin in Healthy Indian Volunteers
Not yet reported GlaxoSmithKline 30 participants Est. completion 2012-02-21Type 2 diabetesView official trial listing → -
Status unknown NCT NCT01565096
Effect of Adding Vildagliptin on Beta Cell Function and Cardiovascular Risk Markers in Patients With Moderate Metabolic Control During Metformin Monotherapy
Not yet reported ikfe-CRO GmbH 44 participants 1 siteOther conditions: Diabetes Mellitus Type IIView official trial listing → -
Completed NCT NCT01570660
Phielix et al.: Hepatic Fat Content and Adipokines
Not yet reported German Diabetes Center 24 participants Est. completion 2012-03 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT01584232
A Study of Dulaglutide in Japanese Participants With Type 2 Diabetes Mellitus
Not yet reported Eli Lilly and Company 361 participants Est. completion 2013-07 15 sites Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT01585792
Double Blind Comparative Study of TAK-875
Not yet reported Takeda 80 participants Est. completion 2012-12 2 sitesOther conditions: Diabetic PatientsView official trial listing → -
Completed NCT NCT01590771
A Study in China Evaluating the Safety and Efficacy of Adding Sitagliptin to Stable Therapy With Sulfonylurea With or Without Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) (MK-0431-253)
Not yet reported Merck Sharp & Dohme LLC 498 participants Est. completion 2014-06-24 Stand-aloneType 2 diabetesView official trial listing → -
Withdrawn NCT NCT01593137
A Long-term Trial to Compare the Effects of Liraglutide and Sulphonylurea (Glimepiride) Both in Combination With Metformin on Clinical, Endothelial and Image Markers of Cardiovascular Risk in Patients With Type 2 Diabetes
Not yet reported Fundación Fernández-Cruz Est. completion 2014-12 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT01610934
The Effects of GLP-1 in Maturity-Onset Diabetes of The Young (MODY)
Not yet reported, Not yet reported University Hospital, Gentofte, Copenhagen 15 participants Est. completion 2013-08 1 siteOther conditions: Maturity-onset Diabetes of the YoungView official trial listing → -
Completed NCT NCT01614769
Effects of Glimepiride on Recovery From Hypoglycemia in Participants With Type 2 Diabetes Mellitus (MK-0000-253)
Not yet reported Merck Sharp & Dohme LLC 10 participants Est. completion 2013-01-23 Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT01624116
Comparison of Hypoglycaemic Regimens During Ramadan Fasting in Type 2 Diabetes
Not yet reported Services Hospital, Lahore 161 participants Est. completion 2011-09 1 siteOther conditions: Diabetes, Type 2View official trial listing → -
Completed NCT NCT01644500
A Study Comparing the Effects and Safety of Dulaglutide With Glimepiride in Type 2 Diabetes Mellitus
Not yet reported Eli Lilly and Company 737 participants Est. completion 2014-08 30 sites Added to GLP-1Type 2 diabetesView official trial listing → -
Completed NCT NCT01649466
Safety and Efficacy of Vildagliptin Versus NPH Insulin add-on to Glimepiride in Type 2 Diabetes Mellitus Patients.
Not yet reported Novartis Pharmaceuticals 162 participants Est. completion 2013-10 53 sites Stand-aloneType 2 diabetesView official trial listing → -
Status unknown NCT NCT01660386
Study of Comparing the Different Effect of DPP-4 Inhibitors and Sulfonylurea by Using "Biphase-Hyperglycemic Clamp"
Not yet reported Shanghai Jiao Tong University School of Medicine 12 participants Est. completion 2013-03 1 site Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT01677247
Bioequivalence Study of 4 mg Glimepiride Tablet
Not yet reported Dexa Medica Group 24 participants Est. completion 2011-03 1 site Stand-aloneOther conditions: Glimepiride BE Study in Healthy Volunteers Under Fasting ConditionView official trial listing → -
Terminated NCT NCT01678820
A Study of the Efficacy and Safety of MK-0431D (a Fixed-dose Combination of Sitagliptin and Simvastatin) for the Treatment of Participants With Type 2 Diabetes Mellitus (T2DM) With Inadequate Glycemic Control on Metformin Monotherapy (MK-0431D-266)
Not yet reported Merck Sharp & Dohme LLC 299 participants Est. completion 2013-11-01 Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT01682759
A Study of the Safety and Efficacy of Omarigliptin (MK-3102) Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-3102-016)
Not yet reported Merck Sharp & Dohme LLC 751 participants Est. completion 2015-01-26 Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT01697592
Omarigliptin (MK-3102) Clinical Trial - Add-on to Oral Antihyperglycemic Agent Study in Japanese Participants With Type 2 Diabetes Mellitus (MK-3102-015)
Not yet reported Merck Sharp & Dohme LLC 585 participants Est. completion 2014-05-08 Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT01699737
Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus
Not yet reported Akros Pharma Inc. 325 participants Est. completion 2013-07 79 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT01699932
Efficacy and Safety of the Fixed Dose Combination of Glimepiride+Metformin in Type 2 Diabetic Patients Inadequately Controlled
Not yet reported Sanofi 167 participants Est. completion 2014-04 13 sites Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT01703286
Trial to Assess the Influence of 4 Weeks' Treatment With Linagliptin as Compared to Glimepiride and Placebo on Endothelial Function in Patients With Type 2 Diabetes Using FMD (Flow-Mediated Vasodilation)
Not yet reported Boehringer Ingelheim 42 participants Est. completion 2014-01 1 site Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT01704261
Addition of Omarigliptin (MK-3102) to Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Combination Therapy With Glimepiride and Metformin (MK-3102-022)
Not yet reported Merck Sharp & Dohme LLC 307 participants Est. completion 2014-12-23 Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT01709305
A Study of the Safety and Efficacy of Glimepiride, Gliclazide, Repaglinide or Acarbose When Added to Sitagliptin + Metformin Combination Therapy in Chinese Participants With Diabetes (MK-0431-313)
Not yet reported Merck Sharp & Dohme LLC 5570 participants Est. completion 2015-04-17Type 2 diabetesView official trial listing → -
Completed NCT NCT01717313
A Study to Assess the Safety and Efficacy of Omarigliptin (MK-3102) in Participants With Type 2 Diabetes Mellitus (T2DM) and Inadequate Glycemic Control (MK-3102-011)
Not yet reported Merck Sharp & Dohme LLC 329 participants Est. completion 2015-06-19 Stand-aloneType 2 diabetesView official trial listing → -
Terminated NCT NCT01725672
Crossover Study to Evaluate the Comparative Bioavailability of Two Fixed Dose Combination Tablet Formulations of Extended Release Metformin and Extended Release Glimepiride in Health Volunteers
Not yet reported GlaxoSmithKline 20 participants Est. completion 2013-08-21 1 site Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT01755156
A Study to Evaluate the Safety, Tolerability, and Efficacy of the Addition of Omarigliptin (MK-3102) to Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin Therapy (MK-3102-024)
Not yet reported Merck Sharp & Dohme LLC 402 participants Est. completion 2016-03-16 Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT01768455
Pharmacokinetic Drug Interaction Study Between Gemigliptin and Glimepiride in Healthy Male Subjects
Not yet reported LG Life Sciences 27 participants 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT01769378
Study of How Dulaglutide Compares to Placebo in Participants With Type 2 Diabetes Who Are Also on Sulfonylurea Therapy (AWARD-8)
Not yet reported Eli Lilly and Company 300 participants Est. completion 2014-12 31 sites Added to GLP-1Type 2 diabetesView official trial listing → -
Completed NCT NCT01794143
A Comparative Effectiveness Study of Major Glycemia-lowering Medications for Treatment of Type 2 Diabetes
Not yet reported GRADE Study Group 7850 participants Est. completion 2021-04-30 36 sitesType 2 diabetes Other conditions: Comparative Effectiveness of Glycemia-lowering MedicationsView official trial listing → -
Completed NCT NCT01812122
Effects of Vildagliptine and Glimepiride on Glucose Variability
Not yet reported Seoul National University Hospital 16 participants Est. completion 2015-10 1 site Stand-aloneOther conditions: Diabetes Mellitus, Non-Insulin-DependentView official trial listing → -
Status unknown NCT NCT01819402
Pioglitazone Decreases Visceral Fat Metabolism
Not yet reported Kurume University 60 participants 1 siteOther conditions: To Evaluate the Effect of Pioglitazone on Glucose Metabolism of Fat Tissue by Using FDG-PET/CT ImagingView official trial listing → -
Terminated NCT NCT01829477
Comparison of TAK-875 to Placebo as an Add-on to Glimepiride in Patients With Type 2 Diabetes
Not yet reported Takeda 33 participants Est. completion 2014-02 69 sites Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT01841697
Study to Evaluate the Safety and Efficacy of the Addition of Omarigliptin (MK-3102) Compared With the Addition of Sitagliptin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-3102-026)
Not yet reported Merck Sharp & Dohme LLC 642 participants Est. completion 2014-11-17 Stand-aloneType 2 diabetesView official trial listing → -
Terminated NCT NCT01863667
A Study to Evaluate the Safety and Efficacy of Omarigliptin (MK-3102) Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus for Whom Metformin is Inappropriate (MK-3102-027)
Not yet reported Merck Sharp & Dohme LLC 65 participants Est. completion 2014-04-03 Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT01890629
Effects of Gemigliptin Versus Sitagliptin or Glimepiride With Metformin on Glucose Variability(MAGE, Glucose SD) Patients With Type 2 DM(STABLE Study)
Not yet reported LG Life Sciences 69 participants Est. completion 2014-08 1 site Stand-aloneType 2 diabetesView official trial listing → -
Terminated NCT NCT01910441
Comparison of Vildagliptin vs. Glimepiride on Glucose Variability in Metformin Uncontrolled Type 2 Diabetic Patients
Not yet reported Novartis Pharmaceuticals 95 participants Est. completion 2014-09Type 2 diabetesView official trial listing → -
Terminated NCT NCT01934816
Incretin and KATP Channels
Not yet reported Katarina Kos 2 participants Est. completion 2015-10 1 site Stand-aloneOther conditions: Healthy SubjectsView official trial listing → -
Terminated NCT NCT01944618
forREAL: FORXIGA PRESCRIPTION EVENT MONITORING PROGRAM (PEMP)
AstraZeneca 5000 participants Est. completion 2015-10 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT01951339
Impact of Sitagliptin on Cardiovascular Exercise Performance in Type 2 Diabetes
Not yet reported University of Colorado, Denver 36 participants Est. completion 2018-06 1 siteType 2 diabetesCardiovascular diseaseView official trial listing → -
Completed NCT NCT01958671
A Study of the Efficacy and Safety of Ertugliflozin Monotherapy in the Treatment of Participants With Type 2 Diabetes Mellitus and Inadequate Glycemic Control Despite Diet and Exercise (MK-8835-003, VERTIS MONO)
Not yet reported Merck Sharp & Dohme LLC 461 participants Est. completion 2016-07-28 Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT01990469
Efficacy and Safety of Gemigliptin 50mg qd Added in Patients With Type 2 Diabetes Inadequately Controlled on Glimepiride and Metformin
Not yet reported LG Life Sciences 219 participants Est. completion 2015-04Type 2 diabetesView official trial listing → -
Completed NCT NCT01999218
Ertugliflozin vs. Glimepiride in Type 2 Diabetes Mellitus (T2DM) Participants on Metformin (MK-8835-002)
Not yet reported Merck Sharp & Dohme LLC 1326 participants Est. completion 2017-04-18 Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT02007278
Glycemic Excursions in Type 2 Diabetic Patients With Vildagliptin and Metformin Versus Vildagliptin and Glimepiride
Not yet reported Novartis Pharmaceuticals 40 participants Est. completion 2016-02-22 8 sitesType 2 diabetes Other conditions: HypoglycemiaView official trial listing → -
Completed NCT NCT02026310
Efficacy/Safety Study of Glimepiride to Type 2 Diabetes Patients Based on Metformin And Basal Insulin Treatment
Not yet reported Qifu Li 40 participants Est. completion 2015-12 1 site Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT02033889
A Study To Evaluate The Efficacy And Safety Of Ertugliflozin In Participants With Type 2 Diabetes Mellitus And Inadequate Glycemic Control On Metformin Monotherapy (MK-8835-007).
Not yet reported Merck Sharp & Dohme LLC 621 participants Est. completion 2017-08-03 Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT02036515
Safety and Efficacy of Ertugliflozin in the Treatment of Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and Sitagliptin (MK-8835-006; VERTIS SITA2)
Not yet reported Merck Sharp & Dohme LLC 464 participants Est. completion 2016-06-06 Stand-aloneType 2 diabetesView official trial listing → -
Terminated NCT NCT02072096
A Comparison of Two Treatment Strategies in Older Participants With Type 2 Diabetes Mellitus (T2DM)
Not yet reported Eli Lilly and Company 192 participants Est. completion 2015-10 34 sitesType 2 diabetesView official trial listing → -
Status unknown NCT NCT02089126
Phase III Trial to Evaluate the Efficacy and Safety of Gemigliptin 50mg qd Added to Ongoing Glimepiride as Fix-dose Combination in Patients With Type 2 Diabetes
Not yet reported LG Life Sciences 230 participants 1 site Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT02098733
Long-term Use of Sonias Combination Tablets in Patients With Type 2 Diabetes Mellitus
Takeda 1168 participants Est. completion 2014-05Type 2 diabetesView official trial listing → -
Completed NCT NCT02098746
Pioglitazone/Glimepiride (Sonias) Combination Tablets Special Drug Use Surveillance Survey in Patients With Type 2 Diabetes Mellitus Who Respond Poorly to Pioglitazone
Takeda 294 participants Est. completion 2014-07Type 2 diabetesView official trial listing → -
Completed NCT NCT02099110
Ertugliflozin and Sitagliptin Co-administration Factorial Study (VERTIS FACTORAL, MK-8835-005)
Not yet reported Merck Sharp & Dohme LLC 1233 participants Est. completion 2016-05-26 Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT02106104
Renal Effects of DPP-4 Inhibitor Linagliptin in Type 2 Diabetes
Not yet reported Amsterdam UMC, location VUmc 48 participants Est. completion 2016-04 1 siteType 2 diabetesView official trial listing → -
Status unknown NCT NCT02142309
Glycemic Durability After Metformin Failure
Not yet reported University of Campania Luigi Vanvitelli 450 participants Est. completion 2017-01 2 sites Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT02172261
Relative Bioavailability of BI 10773 and Glimepiride in Healthy Male Volunteers
Not yet reported Boehringer Ingelheim 16 participants Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT02188186
Therapeutic Efficacy of Triple Combination in Drug-naïve Korean Type 2 Diabetic Patients
Not yet reported Seoul National University Bundang Hospital 200 participants Est. completion 2018-09 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT02226003
Efficacy and Safety of Ertugliflozin (MK-8835/PF-04971729) With Sitagliptin in the Treatment of Participants With Type 2 Diabetes Mellitus (T2DM) With Inadequate Glycemic Control on Diet and Exercise (MK-8835-017)
Not yet reported Merck Sharp & Dohme LLC 291 participants Est. completion 2016-02-23 Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT02280486
Efficacy and Safety of Saxagliptin VS. Glimepiride in Chinese T2DM Patients Controlled Inadequately With Metformin
Not yet reported The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 388 participants Est. completion 2017-10 1 siteType 2 diabetesView official trial listing → -
Status unknown NCT NCT02301806
Effects of Sitaglpitin on Endothelial Function During the OGTT in T2DM
Not yet reported Dokkyo Medical University 30 participants Est. completion 2017-07 2 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT02312063
Dietary Impacts on Glucose-lowering Effects of Sitagliptin in Type 2 Diabetes
Not yet reported Kansai Electric Power Hospital 48 participants Est. completion 2016-05 2 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT02338921
Triple Combination Therapy in Type 2 Diabetic Patients Who Had Inadequate Glycemic Control With Combination Therapy
Not yet reported Seoul National University Bundang Hospital 78 participants Est. completion 2021-12-31 1 siteType 2 diabetesView official trial listing → -
Status unknown NCT NCT02372955
Mechanistic Study of the Systolic Blood Pressure Lowering Effect of Dapagliflozin in Type 2 Diabetes
Not yet reported Gulf Regional Research & Educational Services, LLC 21 participants Est. completion 2016-12 1 siteType 2 diabetesView official trial listing → -
Terminated NCT NCT02373865
Risk of Nocturnal Hypoglycemia and Arrhythmias With Sitagliptin Versus Glimepiride in Patients With Type 2 Diabetes
Not yet reported GWT-TUD GmbH 4 participants Est. completion 2017-01 1 site Stand-aloneType 2 diabetesView official trial listing → -
Withdrawn NCT NCT02395237
COMPOUND (INN): HOE490O - GLIMEPIRIDE / METFORMIN HCl (Amaryl® M)0 (Glimepiride/Metformin Hydrochloride Immediate Release Combination Tablet) in Fed Conditions in Healthy Male and/or Female Subjects.
Not yet reported Pharmaceutical Research Unit, Jordan Est. completion 2015-12 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT02419612
A 52-week International, Multicenter Trial With a Long -Term Extension to Evaluate Saxagliptin With Dapagliflozin in Combination With Metformin Compared to Glimepiride in Combination With Metformin in Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Alone
Not yet reported AstraZeneca 444 participants Est. completion 2019-09-18 84 sites Stand-aloneOther conditions: DiabetesView official trial listing → -
Status unknown NCT NCT02426294
Comparison of Pioglitazone Versus Glimepiride in Type 2 Diabetes Inadequately Controlled With Metformin Plus Alogliptin
Not yet reported Pusan National University Hospital 154 participants Est. completion 2016-05 1 siteType 2 diabetesView official trial listing → -
Status unknown NCT NCT02443922
Dynamic Responsiveness of Insulin Secretory Parameters To Sitagliptin and Glimeperide Administration in Type 2 DM
Not yet reported Foundation for the National Institutes of Health 100 participants Est. completion 2015-12 Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT02456428
Incretin-based Drugs and the Risk of Heart Failure
Canadian Network for Observational Drug Effect Studies, CNODES 1499650 participants Est. completion 2015-05 1 siteType 2 diabetesView official trial listing → -
Status unknown NCT NCT02462369
Saxagliptin's Effects on Microalbuminuria Improvement in Type 2 Diabetic Patients
Not yet reported The Second Hospital of Nanjing Medical University 88 participants Est. completion 2017-10Other conditions: Microalbuminuria, Microalbuminuria /Creatinine Ratios ACRView official trial listing → -
Completed NCT NCT02471404
Efficacy and Safety of Dapagliflozin and Dapagliflozin Plus Saxagliptin in Combination With Metformin in Type 2 Diabetes Patients Compared With Sulphonylurea
Not yet reported AstraZeneca 939 participants Est. completion 2017-03-13 173 sitesType 2 diabetes Other conditions: Inadequate Glycaemic ControlView official trial listing → -
Completed NCT NCT02475499
Incretin-based Drugs and Pancreatic Cancer
Canadian Network for Observational Drug Effect Studies, CNODES 886172 participants Est. completion 2015-04 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT02476760
Incretin-based Drugs and Acute Pancreatitis
Canadian Network for Observational Drug Effect Studies, CNODES 1417914 participants Est. completion 2015-04 1 siteType 2 diabetesView official trial listing → -
Withdrawn NCT NCT02484209
DiaFrail: A Short Duration Study in Older People ( DIAFRAIL Study)
Not yet reported Diabetes Frail Ltd Est. completion 2016-11 Stand-aloneOther conditions: Diabetes MellitusView official trial listing → -
Status unknown NCT NCT02528019
Metabolic and Cardiovascular Effects of Dipeptidyl Peptidase-4 (DPP-4) or Sodium-glucose Co-transporter Type 2 (SGLT2) Inhibitors
Not yet reported Kurume University 100 participants Est. completion 2018-08 1 siteOther conditions: Effects of the DPP-4 Inhibitors or SGLT2 Inhibitors on the Protective Actions for Diabetic ComplicationsView official trial listing → -
Completed NCT NCT02564926
Foxiga Korea Local Phase 4 Study
Not yet reported AstraZeneca 125 participants Est. completion 2018-01-15 14 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT02567994
Tenelia Triple Combination Study
Not yet reported Handok Inc. 201 participants Est. completion 2017-12 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT02609815
Initial Combination of Gemigliptin and Metformin on Microbiota Change
Not yet reported Seoul National University Bundang Hospital 70 participants Est. completion 2021-03-15 1 siteOther conditions: DiabetesView official trial listing → -
Completed NCT NCT02630706
A Study to Evaluate the Efficacy and Safety of Ertugliflozin in Asian Participants With Type 2 Diabetes and Inadequate Glycemic Control on Metformin Monotherapy (MK-8835-012)
Not yet reported Merck Sharp & Dohme LLC 506 participants Est. completion 2017-12-27 Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT02649465
SGLT2 Inhibitor Versus Sulfonylurea on Type 2 Diabetes With NAFLD
Not yet reported Kanazawa University 40 participants Est. completion 2021-06-30 1 siteOther conditions: Non-alcoholic Fatty Liver DiseaseView official trial listing → -
Completed NCT NCT02694263
Canagliflozin (Invokana™) vs. Standard Dual Therapy Regimen for T2DM During Ramadan
Not yet reported University of Leicester 25 participants Est. completion 2018-09-13 2 sites Stand-aloneType 2 diabetesView official trial listing → -
Terminated NCT NCT02728453
SGLT2 Inhibition and Left Ventricular Mass
Not yet reported Hannover Medical School 7 participants Est. completion 2017-09-27 1 site Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT02769481
Safety and Efficacy of Bexagliflozin Compared to Glimepiride as Add-on Therapy to Metformin in Type 2 Diabetes Subjects
Not yet reported Theracos 426 participants Est. completion 2019-06-14 45 sitesType 2 diabetesView official trial listing → -
Status unknown NCT NCT02823808
Effect of Alogliptin/Pioglitazone on the Preservation of Long-term Beta-cell Function
Not yet reported Kyunghee University Medical Center 96 participants Est. completion 2021-12 1 siteOther conditions: DiabetesView official trial listing → -
Status unknown NCT NCT02919059
Study to Asses the Effect of Dapagliflozin on Central Blood Pressure Reduction.
Not yet reported IInstituto Gallego de Medicina Vascular 159 participants Est. completion 2019-08 1 siteType 2 diabetesView official trial listing → -
Status unknown NCT NCT02946632
Effectiveness & Tolerability of Novel, Initial Triple Combination Therapy vs Conventional Therapy in Type 2 Diabetes
Not yet reported Korea University Anam Hospital 104 participants Est. completion 2019-12 1 siteOther conditions: Diabetes Mellitus, Type IIView official trial listing → -
Completed NCT NCT02954822
Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of Evogliptin 5mg and Glimepiride 4mg
Not yet reported Dong-A ST Co., Ltd. 36 participants Est. completion 2017-08-09 1 site Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT02956044
Interaction of Bexagliflozin With Metformin, Glimepiride and Sitagliptin
Not yet reported Theracos 54 participants Est. completion 2017-03 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT02964572
Effect of Sodium Glucose Co-transporter 2 Inhibitor on Inflammatory Cytokine in Type 2 Diabetes
Not yet reported Yonsei University 61 participants Est. completion 2017-07 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT02973477
Dapagliflozin and Measures of Cardiovascular Autonomic Function in Patients With Type 2 Diabetes (T2D)
Not yet reported University of Michigan 45 participants Est. completion 2019-08-22 1 site Stand-aloneType 2 diabetesCardiovascular diseaseView official trial listing → -
Terminated NCT NCT02985242
Empagliflozin Reduces Progression of Diabetic Retinopathy in Patients With High Risk of Diabetic Macular Edema
Not yet reported Hannover Medical School 6 participants Est. completion 2018-08-16 1 site Stand-aloneOther conditions: Diabetes Mellitus, Type IIView official trial listing → -
Completed NCT NCT03009513
Teneligliptin-Glimepiride DDI Study
Not yet reported Handok Inc. 26 participants Est. completion 2017-06 Stand-aloneOther conditions: Diabetes MellitusView official trial listing → -
Terminated NCT NCT03060980
Comparison of Efficacy, Safety, and Tolerability of ITCA 650 to Empagliflozin and Glimepiride as add-on Metformin
Not yet reported Intarcia Therapeutics 245 participants Est. completion 2018-01-26 101 sites Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT03076112
Efficacy of Ipragliflozin Compared With Sitagliptin in Uncontrolled Type 2 Diabetes With Sulfonylurea and Metformin
Not yet reported Seoul National University Bundang Hospital 170 participants Est. completion 2022-08-31 1 site Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT03081676
The Effect of GIP and GLP-1 on Insulin and Glucagon Secretion in Patients With HNF1A-diabetes Treated With or Without Sulphonylurea
Not yet reported University Hospital, Gentofte, Copenhagen 20 participants Est. completion 2018-06-01 1 siteOther conditions: Maturity-Onset Diabetes of the Young, Type 3View official trial listing → -
Terminated NCT NCT03118713
A Study to Evaluate the Renal Protective Effect (Urine Albumin-to-Creatinine Ratio (UACR)), Efficacy and Safety of Ipragliflozin in Type 2 Diabetes Mellitus Patients With Albuminuria
Not yet reported Astellas Pharma Korea, Inc. 33 participants Est. completion 2018-12-12 8 sites Stand-aloneType 2 diabetesView official trial listing → -
Status unknown NCT NCT03180281
Therapies on Newly Diagnosed Type 2 Diabetes Patients With High Glucose Toxicity Which Protect Islet β Cell
Not yet reported First Affiliated Hospital Xi'an Jiaotong University 135 participants Est. completion 2020-01-01 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT03332771
Efficacy and Safety of Sotagliflozin Versus Glimepiride and Placebo in Participants With Type 2 Diabetes Mellitus That Are Taking Metformin Monotherapy
Not yet reported Lexicon Pharmaceuticals 954 participants Est. completion 2019-09-06 142 sites Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT03492580
A Study for Comparison of Canagliflozin Versus Alternative Antihyperglycemic Treatments on Risk of Heart Failure Hospitalization and Amputation for Participants With Type 2 Diabetes Mellitus and the Subpopulation With Established Cardiovascular Disease
Janssen Research & Development, LLC 714582 participants Est. completion 2018-06-25 1 siteType 2 diabetesCardiovascular diseaseView official trial listing → -
Status unknown NCT NCT03585777
Compare Serum Klotho Levels in Patients on Oral Antidiabetic Treatment
Fayoum University 90 participants Est. completion 2019-03 1 siteOther conditions: Compare Serum Level of Klotho in Patients on Oral Antidiabetic TreatmentView official trial listing → -
Completed NCT NCT03648424
Prediction of Findings From the Ongoing CAROLINA Trial Using Healthcare Database Analyses
Brigham and Women's Hospital 48262 participants Est. completion 2019-06-01 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT03693560
Effect of Adding Vildagliptin vs Glimepiride to Metformin on Inflammation's Markers in Type-2 Diabetic Patients With CAD
Not yet reported Damanhour University 80 participants Est. completion 2019-10-10 1 site Stand-aloneCardiovascular diseaseType 2 diabetesView official trial listing → -
Completed NCT NCT03748810
Head-to-head Comparison of Empagliflozin and Dapagliflozin
Chungbuk National University Hospital 600 participants Est. completion 2022-06-30 1 siteType 2 diabetesView official trial listing → -
Status unknown NCT NCT03804411
Prognostic Predictors of Response to Hypoglycemic Therapy
Not yet reported Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health 800 participants Est. completion 2020-05 1 site Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT03907423
Rosuvastatin on Diabetic Patients Treated With Glimepiride/Metformin
Not yet reported Rehab Werida 70 participants Est. completion 2021-01-31 1 site Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT03917940
Omega 3 Fatty Acids on Serum Irisin and Sirtuin-1 in Type 2 Diabetic Mellitus Patients Treated With Glimepiride
Not yet reported Damanhour University 70 participants Est. completion 2020-05-10 1 site Stand-aloneOther conditions: Diabetic PatientsView official trial listing → -
Completed NCT NCT03983551
Comparing the Renal Effect of Dipeptidyl-peptidase 4 Inhibitors and Sulfonylureas
Not yet reported Changhua Christian Hospital 101 participants Est. completion 2018-02-28Type 2 diabetes Other conditions: ProteinuriaView official trial listing → -
Completed NCT NCT04183868
Effects of empagliFlozin on myocardIal metabOlic Rate of glucosE Estimated Through 18FDG PET (FIORE Study)
Not yet reported University of Catanzaro 26 participants Est. completion 2021-10 1 site Stand-aloneType 2 diabetes Other conditions: Cardiovascular Risk FactorView official trial listing → -
Completed NCT NCT04237493
Dosage Reduction and Acute Glycemic Complications in People With Type 2 Diabetes Who Fast During Ramadan
Not yet reported University of Jordan 687 participants Est. completion 2017-07-24 1 site Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT04240171
Dapagliflozin Versus Glimepiride Effect in Patient With Type 2 Diabetes Mellitus
Damanhour University 60 participants Est. completion 2022-01-31 1 siteType 2 diabetesView official trial listing → -
Status unknown NCT NCT04287387
Response of Gut Microbiota in Type 2 Diabetes to Hypoglycemic Agents
Not yet reported Peking Union Medical College Hospital 180 participants Est. completion 2021-03-02 1 site Stand-aloneType 2 diabetesView official trial listing → -
Status unknown NCT NCT04470310
Glimepiride, Alogliptin and Alogliptin+Pioglitazone Combination
Not yet reported Seoul National University Hospital 99 participants Est. completion 2021-08-31Type 2 diabetesView official trial listing → -
Completed NCT NCT04528212
Fenofibrate Versus Curcumin in Type 2 Diabetic Patients
Not yet reported Rehab Werida 60 participants Est. completion 2021-12-01 1 site Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT04841096
Oral Combination of Glimepiride/Vildagliptin/Metformin in Patients With T2D and Dual Treatment Failure
Not yet reported Laboratorios Silanes S.A. de C.V. 162 participants Est. completion 2024-05-15 5 sites Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT05073692
Comparison of Type 2 Diabetes Pharmacotherapy Regimens
Kaiser Permanente 241981 participants Est. completion 2025-03-12 6 sitesType 2 diabetesCardiovascular diseaseView official trial listing → -
Completed NCT NCT05099198
Replication of the GRADE Diabetes Trial in Healthcare Claims Data
Brigham and Women's Hospital 6403 participants Est. completion 2021-08-01 1 siteOther conditions: DiabetesView official trial listing → -
Status unknown NCT NCT05103306
Empagliflozin-based Quadruple Therapy vs Basal Insulin-based Therapy
Chungbuk National University Hospital 300 participants Est. completion 2022-12Type 2 diabetesView official trial listing → -
Status unknown NCT NCT05161429
BESTMED: Observational Evaluation of Second Line Therapy Medications in Diabetes
Brigham and Women's Hospital 550000 participants Est. completion 2024-06-30 5 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT05162183
Replication of the LEAD-2 Diabetes Trial in Healthcare Claims Data
Brigham and Women's Hospital 3474 participants Est. completion 2021-09-01 1 siteOther conditions: DiabetesView official trial listing → -
Status unknown NCT NCT05162690
Efficacy of Dapagliflozin in Diabetes Associated Peripheral Neuropathy
Not yet reported, Not yet reported Post Graduate Institute of Medical Education and Research, Chandigarh 40 participants Est. completion 2023-12-31 1 siteOther conditions: Diabetic Peripheral NeuropathyView official trial listing → -
Active, not recruiting NCT NCT05220917
Comparative Effectiveness and Safety of Four Second Line Pharmacological Strategies in Type 2 Diabetes Study
Brigham and Women's Hospital 781430 participants Est. completion 2027-09-30 1 siteType 2 diabetes Other conditions: Cardiovascular Events, Renal DiseaseView official trial listing → -
Status unknown NCT NCT05386186
The Effect of Glimepiride Compared With Sitagliptin as an add-on Therapy to Metformin in Severe Insulin Deficiency Diabetes
Not yet reported Peking University People's Hospital 192 participants Est. completion 2024-03-31 1 site Stand-aloneType 2 diabetes Other conditions: Severe Insulin Deficient DiabetesView official trial listing → -
Completed NCT NCT05468879
Bioequivalence Study of 3 mg Glimepiride Tablet in Indonesia Healthy Subjects
Not yet reported PT Harsen Laboratories 34 participants Est. completion 2021-01-06 1 site Stand-aloneOther conditions: Drug UseView official trial listing → -
Completed NCT NCT05538819
The Effects of Glimepiride in Patients With Type 2 Diabetes and Chronic Heart Failure
Dao Wen Wang 1018 participants Est. completion 2022-07-01 1 siteHeart failureType 2 diabetes Other conditions: Cardiovascular Mortality, Cohort StudyView official trial listing → -
Status unknown NCT NCT05663736
Effect of Gemigliptin Versus Glimepiride on Cardiac Diastolic Function in Patients With Type 2 Diabetes
Not yet reported Seoul National University Bundang Hospital 80 participants Est. completion 2023-12-31 1 siteOther conditions: Ejection FractionView official trial listing → -
Status unknown NCT NCT05975528
Effect of Sodium-glucose Cotransporter-2 Inhibitor in Cellular Senescence in Patients With Cardiovascular Diseases or Type 2 Diabetes
Not yet reported Yonsei University 92 participants Est. completion 2025-12-31 1 siteOther conditions: Diabetes Mellitus, Cellular Senescence, Sodium-Glucose Transporter 2 InhibitorsView official trial listing → -
Completed NCT NCT06068686
Vildagliptin Versus Glimepiride in Type 2 Diabetic Patients
Not yet reported Damanhour University 70 participants Est. completion 2024-12-01 1 siteType 2 diabetesView official trial listing → -
Status unknown NCT NCT06449235
Real-World Evaluation of Omarigliptin for Type 2 Diabetes Meliitus in Bangladesh
Not yet reported Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders 938 participants Est. completion 2025-06 1 siteOther conditions: Type2diabetesView official trial listing → -
Status unknown NCT NCT06570980
Comparative Analysis of Cost-effectiveness Between Sulfonylureas and DPP4 Inhibitors in Combination With Metformin in Treatment of Type 2 Diabetic Patients : A Retrospective, Observational Study.
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh 200 participants Est. completion 2024-08-30 1 siteType 2 diabetesView official trial listing → -
Not yet recruiting NCT NCT06644404
Phase 1 Study of Drug-Drug Interactions Between DWP16001, DWC202407, and DWC202408 in Healthy Adults
Not yet reported Daewoong Pharmaceutical Co. LTD. 34 participants Est. completion 2025-04-01 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT06759922
Glimepiride, Empagliflozin, and Sitagliptin With Metformin for Type 2 Diabetes
Not yet reported Bahria University 172 participants Est. completion 2025-06-30 1 siteType 2 diabetesView official trial listing → -
Not yet recruiting NCT NCT07288749
Efficacy Evaluation of Glimepiride in Patients With Type 2 Diabetes Mellitus and Chronic Heart Failure With Reduced Ejection Fraction.
Not yet reported Tongji Hospital 1484 participants Est. completion 2031-12-31 1 site Stand-aloneType 2 diabetesHeart failureView official trial listing → -
Not yet recruiting NCT NCT07365358
Evaluate the Efficacy and Safety of Empagliflozin or Glimepiride Combination Therapy in Type 2 Diabetes Mellitus Patients
Not yet reported Chong Kun Dang Pharmaceutical 200 participants Est. completion 2027-08 1 siteOther conditions: Diabete Type 2View official trial listing →
Efficacy history
Not yet reported.
Safety
Not yet reported.
Sources
Related On The Pen coverage
No related coverage yet.
This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.